Back to results
US 11,957,688 B2Granted
Combination therapy with apilimod and glutamatergic agents
AssigneeOrphAl Therapeutics Inc.
InventorsHenri Lichenstein, Sean Landrette, Peter Ronald Young, Jonathan M. Rothberg
Life of this patent
Estimating the term…
Abstract
Provided are compositions and methods related to the use of apilimod in combination with glutamatergic agents for treating neurological diseases and disorders, and for the treatment of cancer.
Claims21
A method for treating a neurological disease or disorder in a subject in need thereof, the method comprising administering to the subject a PIKfyve inhibitor and a glutamatergic agent.
A method for treating a neurological disease or disorder in a subject in need thereof, the method comprising administering to the subject a PIKfyve inhibitor and an antioxidant.
Dependencies are inferred from the claim text.